#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anti-neutrophil cytoplasmic antibody positive vasculitis Glomerulonephritis minimal lesion Antisynthetase syndrome Usher's syndrome Ataxia telangiectasia Hypophosphatasia Idiopathic inflammatory myopathy Heritable pulmonary arterial hypertension Human papilloma virus immunisation Chordoma Hepatic angiosarcoma Arterial tortuosity syndrome Hereditary spastic paraplegia Oesophageal adenocarcinoma stage II Endometrial adenocarcinoma More trials…

    Learn about Rare Diseases

    Extranodal marginal zone B-cell lymphoma (MALT type) Angiosarcoma – Trials in Disease CADASIL – Trials in Disease Glycogen storage disease type V Alexander disease – Basic Information Richter’s syndrome Primary mediastinal large B-cell lymphoma – Treatment Isodicentric chromosome 15 syndrome – Life with Disease Primary immunodeficiency syndrome – Life with Disease KBG syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Toldc Clomipramine Hydrochloride Ivospemin Alxn1850 Imetelstat Sodium Idecabtagene Vicleucel INCB123667 Tak-280 Alkaline Phosphatase, Bovine HTL0022537 Leuprorelin Acetate Temozolomide APROTININ Cagrilintide Imidapril Hydrochloride IMMUNOSTEM Doxycycline Monohydrate Transpocart19 Exemestane Metamizole Magnesium More therapies…

    Learn about Your Condition

    Pancreaticoduodenectomy Post procedural oedema Aortic stenosis Gastrointestinal melanoma Paraganglion neoplasm Cleft lip and palate Glomerulonephritis chronic Arteriovenous graft thrombosis Hypochondroplasia Factor IX deficiency Follicular lymphoma stage IV Pancreatic failure Clinically isolated syndrome Colon cancer stage IV Choroidal neovascularisation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Bladder transitional cell carcinoma stage III

  • Long-Term Study for Cancer Patients Using Atezolizumab Therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Bladder transitional cell carcinoma stage III
    • Non-small cell lung cancer
    • Renal cancer
    Investigated Drugs:
    • Atezolizumab
    Austria Czechia France Hungary Poland Spain

  • Study on Durvalumab with Trimodality Therapy for Patients with Muscle-Invasive Bladder Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Bladder transitional cell carcinoma stage II
    • Bladder transitional cell carcinoma stage III
    Investigated Drugs:
    • Durvalumab
    Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!